Szczegóły publikacji
Opis bibliograficzny
Injectable platelet-rich fibrin (I-PRF) administered to temporomandibular joint cavities: a scoping review / Marcin Sielski, Kamila CHĘCIŃSKA, Maciej Chęciński, Maciej Sikora // Journal of Clinical Medicine [Dokument elektroniczny]. — Czasopismo elektroniczne ; ISSN 2077-0383. — 2023 — vol. 12 iss. 9 art. no. 3326, s. 1–15. — Wymagania systemowe: Adobe Reader. — Bibliogr. s. 12–15, Abstr. — Publikacja dostępna online od: 2023-05-07
Autorzy (4)
- Sielski Marcin
- AGHChęcińska Kamila
- Chęciński Maciej Adam
- Sikora Maciej
Słowa kluczowe
Dane bibliometryczne
| ID BaDAP | 148040 |
|---|---|
| Data dodania do BaDAP | 2023-08-11 |
| Tekst źródłowy | URL |
| DOI | 10.3390/jcm12093326 |
| Rok publikacji | 2023 |
| Typ publikacji | przegląd |
| Otwarty dostęp |  |
| Creative Commons | |
| Czasopismo/seria | Journal of Clinical Medicine |
Abstract
The aim of this review was to systematically map the research on the intra-articular administration of injectable platelet-rich fibrin (I-PRF) to the temporomandibular joints (TMJs). Medical databases covered by the ACM, BASE, Google, NLM, and ResearchGate were searched on 23 February 2023. The assessment of the level of evidence was based on the Oxford Center for Evidence-Based Medicine 2011 scale. The risk of bias was assessed for randomized controlled trials with the RoB2 tool. Extracted data were tabulated, and the changes in effect values were calculated. A total of eight studies qualified, of which five trials on 213 patients were randomized and controlled (RCTs). In each of the RTC study groups, arthrocentesis was performed, and 1-2 mL per joint of I-PRF (700 rpm/3 min/60 g centrifugation) was administered. Articular pain in three months decreased to 0-25% of the initial pre-interventional values in the study and 38-50% in the control groups. Mandible mobility increased to 121-153% and 115-120% in the I-PRF groups and controls, respectively. The main limitations of the evidence were the small number of RCTs and the lack of any RCT study groups receiving I-PRF without prior arthrocentesis. In conclusion, supplementing the temporomandibular joint rinsing with I-PRF administration further relieves pain and improves mandible mobility. The lack of RCTs on the intra-articular administration of I-PRF as a stand-alone procedure encourages further research. This research received no external funding. The review protocol has not been previously published.
